ClassID:

117105

C12Y304/24087 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Metalloendopeptidases (3.4.24) ADAMTS13 endopeptidase (3.4.24.87)

Recent Application in this class:
#1
20260102719
2026-04-16

DUAL-SPECIFIC BINDING MOLECULE USEFUL FOR ISOLATING SPECIFIC BLOOD CELLS

#2
20260092101
2026-04-02

METHOD FOR TREATING SEPSIS AND RELATED DISEASES

#3
20260062691
2026-03-05

METHODS OF PURIFYING RECOMBINANT ADAMTS13 AND OTHER PROTEINS AND COMPOSITIONS THEREOF

#4
20250361499
2025-11-27

Thrombolytic Protease Resistant ADAMTS13 Mutants

#5
20250302744
2025-10-02

NOVEL LIQUID FORMULATION FOR PLASMA PROTEIN

#6
20250270563
2025-08-28

TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT

#7
20250099559
2025-03-27

STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS

#8
20240124865
2024-04-18

ADAMTS13 VARIANT

#9
20240067947
2024-02-29

TRUNCATED MODIFIED RECOMBINANT ADAMTS13 AND USES THEREOF

#10
20230405096
2023-12-21

ADAMTS13 VARIANT HAVING INCREASED ESCAPING RATE OR ACTIVITY AGAINST AUTOANTIBODY

#11
20230295597
2023-09-21

A DISINTEGRIN AND METALLOPROTEINASE WITH A THROMBOSPONDIN TYPE I MOTIF, MEMBER 13 (ADAMTS-13) MUTANTS, COMPOSITIONS AND THERAPEUTIC METHODS THEREOF

#12
20230242897
2023-08-03

METHODS OF PURIFYING RECOMBINANT ADAMTS13 AND OTHER PROTEINS AND COMPOSITIONS THEREOF

#13
20230242896
2023-08-03

ADAMTS13 PROTEIN VARIANTS AND USES THEREOF

#14
20230203469
2023-06-29

ADAMTS13 VARIANT, COMPOSITIONS, AND USES THEREOF

#15
20230201319
2023-06-29

ADAMTS13 COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING COMPLICATIONS OF CORONAVIRUS DISEASE

#16
20230130866
2023-04-27

Stabilized liquid and lyophilized ADAMTS13 formulations

#17
20220249628
2022-08-11

USE OF RECOMBINANT ADAMTS13 FOR TREATING SICKLE CELL DISEASE

#18
20220213462
2022-07-07

RED BLOOD CELLS EXPRESSING VON WILLEBRAND FACTOR PROTEASE AND METHODS OF USE THEREOF

#19
20220080032
2022-03-17

Subcutaneous administration of ADAMTS13

#20
20210128701
2021-05-06

COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION

#21
20210115110
2021-04-22

Method of producing recombinant high molecular weight vWF in cell culture

#22
20210108208
2021-04-15

TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT

#23
20200376098
2020-12-03

Stabilized liquid and lyophilized ADAMTS13 formulations

#24
20200308566
2020-10-01

ADAMTS13 protein cell culture supernatant

#25
20200101144
2020-04-02

Subcutaneous administration of ADAMTS13

#26
20190369095
2019-12-05

NOVEL ANTIBODY FOR DETERMINATION OF ADAMTS-13 ACTIVITY

#27
20190247475
2019-08-15

Stabilized liquid and lyophilized ADAMTS13 formulations

#28
20190153400
2019-05-23

Method of producing a polypeptide or virus of interest in a continuous cell culture

#29
20190085052
2019-03-21

Method of producing recombinant high molecular weight vWF in cell culture

#30
20190071660
2019-03-07

Cell culture methods for expressing ADAMTS protein

#31
20190031771
2019-01-31

Human monoclonal autoantibodies to ADAMTS13 and uses thereof

#32
20180362987
2018-12-20

Targeted augmentation of nuclear gene output

#33
20180326024
2018-11-15

MATERIALS AND METHODS FOR TREATING EMBOLISM

#34
20180207245
2018-07-26

Stabilized liquid and lyophilized ADAMTS13 formulations

#35
20180147265
2018-05-31

METHODS RELATING TO THE TREATMENT OF COLITIS AND INFLAMMATORY BOWEL DISEASE

#36
20180110842
2018-04-26

COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION

#37
20180051261
2018-02-22

Method of producing a polypeptide or virus of interest in a continuous cell culture

#38
20180044405
2018-02-15

Method of producing recombinant high molecular weight vWF in cell culture

#39
20170224785
2017-08-10

Subcutaneous administration of ADAMTS13

#40
20170112906
2017-04-27

Stabilized liquid and lyophilized ADAMTS13 formulations

#41
20170065686
2017-03-09

Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV

#42
20170051270
2017-02-23

Cell culture methods for expressing ADAMTS13 protein

#43
20170008948
2017-01-12

Method of producing recombinant high molecular weight vWF in cell culture

#44
20160375111
2016-12-29

Stabilized liquid and lyophilized ADAMTS13 formulations

#45
20160298121
2016-10-13

Targeted augmentation of nuclear gene output

#46
20160244506
2016-08-25

CELL CULTURE PROCESSES

#47
20150329848
2015-11-19

Cell culture medium for ADAMTS protein expression

#48
20150104849
2015-04-16

Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

#49
20150056657
2015-02-26

METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE

#50
20150050716
2015-02-19

ADAMTS-13 mutant

#51
20150044171
2015-02-12

Gain-of-function ADAMTS13 variants resistant to auto antibody inhibition and methods of use thereof

#52
20150018525
2015-01-15

Method of producing recombinant high molecular weight vWF in cell culture

#53
20140335071
2014-11-13

Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV

#54
20120064057
2012-03-15

ADAMTS-13 mutant

#55
20120035110
2012-02-09

Method of producing recombinant high molecular weight vWF in cell culture

#56
20120034674
2012-02-09

Method of producing recombinant ADAMTS13 in cell culture

#57
20110229455
2011-09-22

Stabilized liquid and lyophilized ADAMTS13 formulations

#58
20110086413
2011-04-14

Methods for expressing ADAMTS proteins in cell culture medium supplemented with zinc

#59
20110086411
2011-04-14

Method of producing a polypeptide or virus of interest in a continuous cell culture

#60
20110081700
2011-04-07

Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

#61
20090203110
2009-08-13

Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV

#62
20090176269
2009-07-09

Cell culture processes

#63
20090017467
2009-01-15

Composition exhibiting a von Willebrand Factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV

#64
20080176312
2008-07-24

Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV

#65
20050266528
2005-12-01

Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV